Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Paraproteinemias 1Nervous System Diseases 1Neoplasms, Plasma Cell 1Myasthenia Gravis 1Multiple Myeloma 1Kidney Diseases 1Hematologic Diseases 1Autoimmune Diseases 1Acute Kidney Injury 1

Interventions

Dexamethasone 363Bortezomib 232Lenalidomide 202Cyclophosphamide 174Melphalan 154Calcium Dobesilate 107Peripheral Blood Stem Cell Transplantation 92fludarabine phosphate 84Thalidomide 81Filgrastim 71carfilzomib 68pomalidomide 66Granulocyte Colony-Stimulating Factor 60Mycophenolic Acid 59Busulfan 57daratumumab 55Whole-Body Irradiation 54Tacrolimus 51ixazomib 50Prednisone 50Cyclosporine 49fludarabine 46Antilymphocyte Serum 35Etoposide 30dexamethasone acetate 29Methotrexate 29plerixafor 27Radiotherapy 26Doxorubicin 26dexamethasone 21-phosphate 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Multiple Myeloma × Plasma Exchange × Clear all
NCT00120263 2025-03-25

Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Completed
92 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Neoplasms, Plasma Cell, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡